This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.

Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided for the purpose of scientific exchange.

The website is not country specific and may therefore contain information that is not applicable in your country, thus you may find information concerning study drugs or therapeutic uses that have not been approved by drug regulatory agencies. This website is not intended to promote in any way, any use, either approved, or unapproved, of a Novo Nordisk product or of any other product or serve as basis for any treatment decision or action. Please always refer to Summary of Product Characteristics (product label) as approved by regulatory authorities in your country or contact Novo Nordisk for further information.

Furthermore, the site is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. Only a physician can determine whether a specific product is correct for a particular patient. Novo Nordisk accepts no liability for the accuracy, completeness or use of this information, and disclaims any liability to update the information contained on this site.

By accessing this website you accept this legal notice and expressly confirm your status as a healthcare professional.

Sean

Wharton

Wharton Medical Clinic, Toronto, Canada

Dr. Wharton has his doctorate in Pharmacy and Medicine at the University of Toronto. He is the medical director of the Wharton Medical Clinic, a community based internal medicine weight management and diabetes clinic. He is an adjunct professor at McMaster University in Hamilton and York University in Toronto. He also academic staff at Women’s College Hospital, and clinical staff the Hamilton Health Sciences. Dr. Wharton’s research focuses on bariatric medicine and type 2 diabetes. He is the co-lead authour of the Canadian Obesity Guidelines

Dr. Wharton is involved activism to achieve health equity in Canada. He founded the BMSA (Black Medical Students Association) at the University of Toronto in 2000. The BMSA is now a recognized mentorship organization across Canada.

Carel le Roux

Ulster University, Coleraine, Northern Ireland

Professor Carel le Roux graduated from medical school in Pretoria South Africa, completed his specialist training in metabolic medicine at St Bartholomew’s Hospitals and the Hammersmith Hospitals. He obtained his PhD from Imperial College London where he later took up a faculty position. He moved to University College Dublin for the Chair in Experimental Pathology and he is now a Director of the Metabolic Medicine Group. He also holds the position of Professor of Metabolic Medicine at Ulster University and Extra-ordinary Professor of Chemical Pathology at University of Pretoria. He currently coordinates an Innovative Medicine Initiative project on obesity. He previously received a President of Ireland Young Researcher Award, Irish Research Council Laurate Award, Clinician Scientist Award from the National Institute Health Research in the UK, and a Wellcome Trust Clinical Research Fellowship for his work on how the gut talks to the brain.

Read full bio

Domenica Rubino

Washington Center for Weight Management & Research, Arlington, VA, USA

Domenica Rubino is the founder and Director of the Washington Center for Weight Management & Research in Arlington, VA, USA, a comprehensive weight management programme utilising a multidisciplinary team for the care of the individuals with obesity. Dr Rubino is board certified in Obesity Medicine, Endocrinology, Diabetes & Metabolism, and Internal Medicine and received training in both clinical and molecular biological research at the US National Institutes of Health. She has extensive experience in the care of the overweight patient and has conducted clinical research for the development of pharmaco-therapeutic agents in the management of obesity. She is currently a clinical investigator for AstraZeneca, Boehringer Ingelheim and Novo Nordisk, and is the recipient of an independent research grant from Obesinov, SARL.

She currently serves as a clinical expert on the treatment of obesity for several professional committees, and as a consultant and speaker for Novo Nordisk, and has also served as a representative to Congress and outside organisations for The Obesity Society. She often speaks as an advocate for the person struggling with obesity and has a strong interest in the psychological impact and societal stigma of this medical condition.

Dr Rubino has received several investigator awards, and has and has authored select peer-reviewed publications (including JAMA, Lancet, Obesity, the European Journal of Endocrinology, the Journal of Clinical Endocrinology and Metabolism and Diabetes, Obesity and Metabolism), and recently contributed a chapter on ‘Biopsychosocial Modifiers of Obesity’ for the textbook entitled Bariatric Endocrinology, published by Springer Verlag.

Read full bio

Paolo Sbraccia

Department of Systems Medicine, University of Rome, Rome, Italy

Paolo Sbraccia, M.D, Ph.D. is Professor of Internal Medicine in the Department of Systems Medicine of the University of Rome "Tor Vergata", Chief of the Internal Medicine Unit and Obesity Center (EASO accredited Collaborating Centre for Obesity Management) at the University Hospital Policlinico Tor Vergata, Director of the Specialization School in Internal Medicine, and Chairman of the Undergraduate Course in Dietetics.

Prof. Sbraccia is also currently serving as Treasurer and member of the Board of Trustees of the European Association for the Study of Obesity (EASO), and Vice President of the Italian Barometer Diabetes Observatory. In addition, he is Past President of the Italian Society of Obesity and of the Italian Federation of Endocrinology, Diabetology, Andrology, Metabolism and Obesity.

He was also member of the “Scientific Advisory Group for Diabetes and Endocrinology” of the European Medicine Agency (EMA, 2008-2015).

In 2011, on behalf of SIO, he coordinated the Steering Committee for the Italian Guidelines for the Management of Obesity, and in 2016 he was Editor of the book “Clinical Management of Overweight and Obesity, Recommendations of the Italian Society of Obesity (SIO)”.

Prof. Sbraccia is also a member of the editorial boards and reviewer panels of various scientific journals; in particular, he is Section Editor for Diabetes and Endocrinology of “Eating and weight disorders” and associate Editor “Internal and Emergency Medicine”.

Read full bio